BibTex RIS Kaynak Göster

Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats.

Yıl 2011, Cilt: 8 Sayı: 1, 46 - 52, 01.03.2011

Shrinivas S Sharma Shrinivass S Sharma

Öz

Anahtar Kelimeler

-

Kaynakça

  • Path FRC, Ali Abdel S. An update on the pathogenesis and pathology of Hepatocellular Carcinoma. Bah Med Bull 2007;29:1-8.
  • Asmaa IG, Shahid AK, Mireille BT, Imam W, Simon D, Robinson T. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J of Gastroenterol 2008;14:4300-8.
  • Noore A, Monica R, Deborah B. Epidemiology of primary liver cancer. Cancer Forum 2009;33:1-5.
  • Daniel MK, Daniel ZV, Misael U, Nahum MS. Hepatocellular carcinoma: An overview. Annal Hep 2006;5:16-24.
  • William FW, Agostino M. Captopril as a chemopreventive agent. Free Patent Online 1993; Pt no.5192524.
  • Amitai E, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, MorOron H, Rosenthal T. The Effects of Allicin on Weight in Fructose-Induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats. American J Hyper 2003;16:1053-6.
  • Miron T, Rabinkov A, Peleg E, et al. Allylmercaptocaptopril: a new antihypertensive drug. Am J Hypertens 2004; 17: 71-3.
  • Stoll A, Seebeck E. Die synthesis des naturlichen Aliins und senier drei optish aktiven Isomerasen. Hel Chem Acta 1948;31:189-210.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-Phenol reagents. J Biol Chem 1951;193:265-75.
  • Darrow RA, Colowick SP. Methods Enzymol 1962; 226-7.
  • Horrocks JE, Ward J, King JA. A routine method for the determination of phosphoglucoisomerase activity in body fluid. J Clin Pathol 1963;16: 248-52.
  • Bergmeyer HU. Methods of Enzymatic Analysis, Second Edition, 1974, Volume I, 430
  • Taussky HH, Shorr EJ. Biol Chem 1953; 202:675-85.
  • Nordlie, RC, Arion WJ. Methods Enzymology 1966;9:619- 25.
  • Gancedo JM, Gancedo C. Fructose 1,6-disphosphatase, phospho fructokinase and glucose-6-phosphate dehydro- genase from fermenting and non-fermenting yeasts. Arch Microbiol 1971;76:132-8.
  • Kamali M, Manhouri H. A Modified Orcinol Reaction for RNA Determination. Clin Chem 1969;15:390-2.
  • Burton K. A Study of the Conditions and Mechanism of the Diphenylamine Reaction for the Colorimetric Estimation of Deoxyribonucleic Acid. Biochem J 1956;62:315-23.
  • Bannasch P, Mayer D, Hacker HJ. Hepatocellular glyco- genesis and hepatocarcinogenesis. Biochim Biophys Acta 1980;605:217-45.
  • Hertzfeld A, Greengard O. Enzyme activities in human fe- tal and neoplastic tissues. Cancer 1980;46:2047-54.
  • Parry DM, Pedersen PL. Intracellular localization and properties of particulate hexokinase in the Novikoff asci- tes tumour. J Biol Chem 1983;258:10904-12.
  • Arora KK, Pedersen PL. Functional significance of mito- chondrial bound hexokinase in tumour cell metabolism. J Biol Chem 1988;263:17422-28.
  • Campbell DM, King, EJ. Serum phosphatases and glyco- lytic enzymes in cancer of the breast. Biochem J 1962; 82:23-8.
  • Hennipman A, Van Oirschot BA, Smits J, Rijksen G,Stacil GEJ. Heterogeneity of glycolytic enzyme activity and iso- zyme composition of pyruvate kinase in breast cancer. Tumour Biol 1988;9:178-88.
  • Quistorff, B. Gluconeogenesis in periportal and perive- nous hepatocytes of rat liver, isolated by a new high-yield digitonin/ collagenase perfusion technique. Biochem J 1985;229:221-6.
  • Graham MM, Spence AM, Muzi M, Abbot GL. Deoxyglucose kinetics in rat brain tumour. J CerebBlood Flow Metab 1989;9:315-22.
  • Weber G, Cantero A. Comparison of carbohydrate metab- olism in normal and neoplastic liver. EnzymeStudies. Acta Unio Internat Contra Cancrum 1960;16:1002.
  • Ellis EN, Burnette JJ, Sedlack R, Dyas C, Blackemore WSA. Surgery 1991;173:329.
  • Lancaster MC. Comparative Aspects of Aflatoxin-induced Hepatic Tumors. Cancer Research 1968; 28:2288-92.
  • Roebuck BD, Maxuitenko YY. In: Eaton DL, Groopman JD, editors. Toxicology of aflatoxins. San Diego: Academic Press, 1994:27-43.

Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats.

Yıl 2011, Cilt: 8 Sayı: 1, 46 - 52, 01.03.2011

Shrinivas S Sharma Shrinivass S Sharma

Öz

-

Anahtar Kelimeler

-

Kaynakça

  • Path FRC, Ali Abdel S. An update on the pathogenesis and pathology of Hepatocellular Carcinoma. Bah Med Bull 2007;29:1-8.
  • Asmaa IG, Shahid AK, Mireille BT, Imam W, Simon D, Robinson T. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J of Gastroenterol 2008;14:4300-8.
  • Noore A, Monica R, Deborah B. Epidemiology of primary liver cancer. Cancer Forum 2009;33:1-5.
  • Daniel MK, Daniel ZV, Misael U, Nahum MS. Hepatocellular carcinoma: An overview. Annal Hep 2006;5:16-24.
  • William FW, Agostino M. Captopril as a chemopreventive agent. Free Patent Online 1993; Pt no.5192524.
  • Amitai E, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, MorOron H, Rosenthal T. The Effects of Allicin on Weight in Fructose-Induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats. American J Hyper 2003;16:1053-6.
  • Miron T, Rabinkov A, Peleg E, et al. Allylmercaptocaptopril: a new antihypertensive drug. Am J Hypertens 2004; 17: 71-3.
  • Stoll A, Seebeck E. Die synthesis des naturlichen Aliins und senier drei optish aktiven Isomerasen. Hel Chem Acta 1948;31:189-210.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-Phenol reagents. J Biol Chem 1951;193:265-75.
  • Darrow RA, Colowick SP. Methods Enzymol 1962; 226-7.
  • Horrocks JE, Ward J, King JA. A routine method for the determination of phosphoglucoisomerase activity in body fluid. J Clin Pathol 1963;16: 248-52.
  • Bergmeyer HU. Methods of Enzymatic Analysis, Second Edition, 1974, Volume I, 430
  • Taussky HH, Shorr EJ. Biol Chem 1953; 202:675-85.
  • Nordlie, RC, Arion WJ. Methods Enzymology 1966;9:619- 25.
  • Gancedo JM, Gancedo C. Fructose 1,6-disphosphatase, phospho fructokinase and glucose-6-phosphate dehydro- genase from fermenting and non-fermenting yeasts. Arch Microbiol 1971;76:132-8.
  • Kamali M, Manhouri H. A Modified Orcinol Reaction for RNA Determination. Clin Chem 1969;15:390-2.
  • Burton K. A Study of the Conditions and Mechanism of the Diphenylamine Reaction for the Colorimetric Estimation of Deoxyribonucleic Acid. Biochem J 1956;62:315-23.
  • Bannasch P, Mayer D, Hacker HJ. Hepatocellular glyco- genesis and hepatocarcinogenesis. Biochim Biophys Acta 1980;605:217-45.
  • Hertzfeld A, Greengard O. Enzyme activities in human fe- tal and neoplastic tissues. Cancer 1980;46:2047-54.
  • Parry DM, Pedersen PL. Intracellular localization and properties of particulate hexokinase in the Novikoff asci- tes tumour. J Biol Chem 1983;258:10904-12.
  • Arora KK, Pedersen PL. Functional significance of mito- chondrial bound hexokinase in tumour cell metabolism. J Biol Chem 1988;263:17422-28.
  • Campbell DM, King, EJ. Serum phosphatases and glyco- lytic enzymes in cancer of the breast. Biochem J 1962; 82:23-8.
  • Hennipman A, Van Oirschot BA, Smits J, Rijksen G,Stacil GEJ. Heterogeneity of glycolytic enzyme activity and iso- zyme composition of pyruvate kinase in breast cancer. Tumour Biol 1988;9:178-88.
  • Quistorff, B. Gluconeogenesis in periportal and perive- nous hepatocytes of rat liver, isolated by a new high-yield digitonin/ collagenase perfusion technique. Biochem J 1985;229:221-6.
  • Graham MM, Spence AM, Muzi M, Abbot GL. Deoxyglucose kinetics in rat brain tumour. J CerebBlood Flow Metab 1989;9:315-22.
  • Weber G, Cantero A. Comparison of carbohydrate metab- olism in normal and neoplastic liver. EnzymeStudies. Acta Unio Internat Contra Cancrum 1960;16:1002.
  • Ellis EN, Burnette JJ, Sedlack R, Dyas C, Blackemore WSA. Surgery 1991;173:329.
  • Lancaster MC. Comparative Aspects of Aflatoxin-induced Hepatic Tumors. Cancer Research 1968; 28:2288-92.
  • Roebuck BD, Maxuitenko YY. In: Eaton DL, Groopman JD, editors. Toxicology of aflatoxins. San Diego: Academic Press, 1994:27-43.
Toplam 29 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Makaleler
Yazarlar

Shrinivas S Sharma Bu kişi benim

Shrinivass S Sharma Bu kişi benim

Yayımlanma Tarihi 1 Mart 2011
Yayımlandığı Sayı Yıl 2011 Cilt: 8 Sayı: 1

Kaynak Göster

APA Sharma, S. S., & Sharma, S. S. (2011). Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats. European Journal of General Medicine, 8(1), 46-52.
AMA Sharma SS, Sharma SS. Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats. European Journal of General Medicine. Mart 2011;8(1):46-52.
Chicago Sharma, Shrinivas S, ve Shrinivass S Sharma. “Anticarcinogenic Activity of Allylmercaptocaptopril Against AflatoxinB1 Induced Liver Carcinoma in Rats”. European Journal of General Medicine 8, sy. 1 (Mart 2011): 46-52.
EndNote Sharma SS, Sharma SS (01 Mart 2011) Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats. European Journal of General Medicine 8 1 46–52.
IEEE S. S. Sharma ve S. S. Sharma, “Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats”., European Journal of General Medicine, c. 8, sy. 1, ss. 46–52, 2011.
ISNAD Sharma, Shrinivas S - Sharma, Shrinivass S. “Anticarcinogenic Activity of Allylmercaptocaptopril Against AflatoxinB1 Induced Liver Carcinoma in Rats”. European Journal of General Medicine 8/1 (Mart 2011), 46-52.
JAMA Sharma SS, Sharma SS. Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats. European Journal of General Medicine. 2011;8:46–52.
MLA Sharma, Shrinivas S ve Shrinivass S Sharma. “Anticarcinogenic Activity of Allylmercaptocaptopril Against AflatoxinB1 Induced Liver Carcinoma in Rats”. European Journal of General Medicine, c. 8, sy. 1, 2011, ss. 46-52.
Vancouver Sharma SS, Sharma SS. Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats. European Journal of General Medicine. 2011;8(1):46-52.